Multiparametric magnetic resonance imaging of the prostate: Current status in prostate cancer detection, localization, and staging

被引:26
作者
Macura, Katarzyna J. [1 ]
机构
[1] Johns Hopkins Med Inst, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
关键词
D O I
10.1053/j.ro.2008.06.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
MRI has been shown to be a useful imaging technique for prostate cancer detection, localization, and staging. Currently, state of-the-art prostate MRI should be performed using a combined endorectal and surface pelvic coil with a magnetic field strength of at least 1.5 T. With the increasing experience and standardization of imaging protocols at 3 T, true gains in SNR will be fully translated into improved diagnostic performance. For prostate cancer detection the combined conventional MRI, providing anatomic detail, and functional MRI approach, providing additional metabolic/perfusion information, has shown promising results. Combined conventional and functional MRI approach seems to be most useful for patients with elevated or increasing PSA and negative TRUS biopsies, and for staging high-risk patients who are at risk for ECE. Functional techniques may allow for in vivo assessment of tumor aggressiveness. A combined conventional and functional MRI approach may play a role in monitoring patients with prostate cancer who select watchful waiting or other new minimally invasive cancer therapies. MRI still has several limitations, mainly limited availability, high costs, and the lack of standardized imaging parameters. Differentiation between prostate cancer and prostatitis is still a major problem, as both MRSI and DCE-MRI may demonstrate in prostatitis metabolic/perfusion abnormality that leads to false-positive diagnosis of cancer. The overlap between ADC values for cancer and benign tissues in the prostate also affect the specificity of DWI. MRI of the prostate is still evolving and as the technology matures and new tools for analysis of vast data from multiparametric imaging become available, we should expect that MRI's role will solidify. However, larger clinical studies are necessary, to allow us to fully understand and document the value of MRI in prostate cancer diagnosis and management. © 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 100 条
[1]
*ACS, 2006, PUBL AM CANC SOC
[2]
Dynamic contrast enhanced MRI in prostate cancer [J].
Alonzi, Roberto ;
Padhani, Anwar R. ;
Allen, Clare .
EUROPEAN JOURNAL OF RADIOLOGY, 2007, 63 (03) :335-350
[3]
Barentsz JO, 1999, J MAGN RESON IMAGING, V10, P295, DOI 10.1002/(SICI)1522-2586(199909)10:3<295::AID-JMRI10>3.0.CO
[4]
2-Z
[5]
BASHAR I, 2002, J MAGN RESON IMAGING, V16, P196
[6]
Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate [J].
Bernstein, MR ;
Cangiano, T ;
D'Amico, A ;
Chittams, J ;
Hardy, C ;
Whittington, RD ;
Tomaszewski, JE ;
Schnall, MD ;
Wein, AJ ;
Malkowicz, SB .
UROLOGIC ONCOLOGY, 2000, 5 (03) :104-107
[7]
PROSTATIC-CARCINOMA - STAGING WITH MR IMAGING AT 1.5-T [J].
BEZZI, M ;
KRESSEL, HY ;
ALLEN, KS ;
SCHIEBLER, ML ;
ALTMAN, HG ;
WEIN, AJ ;
POLLACK, HM .
RADIOLOGY, 1988, 169 (02) :339-346
[8]
Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: The Krimpen study [J].
Bosch, JLHR ;
Bohnen, AM ;
Groeneveld, FPMJ .
EUROPEAN UROLOGY, 2004, 46 (06) :753-759
[9]
Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL [J].
Bozeman, CB ;
Carver, BS ;
Caldito, G ;
Venable, DD ;
Eastham, JA .
UROLOGY, 2005, 66 (04) :803-807
[10]
THE ROLE OF INTRAVENOUS CONTRAST ENHANCEMENT IN MAGNETIC-RESONANCE-IMAGING OF PROSTATIC-CARCINOMA [J].
BROWN, G ;
MACVICAR, DA ;
AYTON, V ;
HUSBAND, JE .
CLINICAL RADIOLOGY, 1995, 50 (09) :601-606